An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction.
暂无分享,去创建一个
Wei Wang | Baoyu Tan | Jingrui Chen | Yuanlu Cui | Yingying Shang | Guanwei Fan | Wenguang Liu | Guanwei Fan | Wei Wang | Yuanlu Cui | Jingrui Chen | Hui-zhen Jia | Wenguang Liu | Rui Bao | Xuran Zhang | Shuang Liang | Wei Liang | Huizhen Jia | Wei-Gang Liang | Baoyu Tan | Rui Bao | Shuang Liang | Xuran Zhang | Yingying Shang
[1] F. R. Formiga,et al. Cardiac Regeneration using Growth Factors: Advances and Challenges , 2016, Arquivos brasileiros de cardiologia.
[2] Chi H. Lee,et al. Effects of nitric oxide on stem cell therapy. , 2015, Biotechnology advances.
[3] Joseph C. Wu,et al. Cross Talk of Combined Gene and Cell Therapy in Ischemic Heart Disease: Role of Exosomal MicroRNA Transfer , 2014, Circulation.
[4] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[5] M. Hedrick,et al. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes , 2006, Nature Clinical Practice Cardiovascular Medicine.
[6] Xin Jia,et al. AuNP–Collagen Matrix with Localized Stiffness for Cardiac‐Tissue Engineering: Enhancing the Assembly of Intercalated Discs by β1‐Integrin‐Mediated Signaling , 2016, Advanced materials.
[7] Patrick W Serruys,et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.
[8] R. Cecere,et al. Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction. , 2013, Interactive cardiovascular and thoracic surgery.
[9] S. Solomon,et al. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial) , 2015, European heart journal.
[10] I. Shapira,et al. Ischaemia or reperfusion: which is a main trigger for changes in nitric oxide mRNA synthases expression? , 2005, European journal of clinical investigation.
[11] Yen Wei,et al. In vitro study of electroactive tetraaniline-containing thermosensitive hydrogels for cardiac tissue engineering. , 2014, Biomacromolecules.
[12] W. Koch,et al. Cardiovascular gene therapy for myocardial infarction , 2014, Expert opinion on biological therapy.
[13] Doris A Taylor,et al. Maximizing Cardiac Repair: Should We Focus on the Cells or on the Matrix? , 2017, Circulation research.
[14] Seppo Ylä-Herttuala,et al. Cardiovascular Gene Therapy: Past, Present, and Future. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] P. Ma,et al. Interwoven Aligned Conductive Nanofiber Yarn/Hydrogel Composite Scaffolds for Engineered 3D Cardiac Anisotropy. , 2017, ACS nano.
[16] F. Prósper,et al. Hydrogel based approaches for cardiac tissue engineering. , 2017, International journal of pharmaceutics.
[17] P. Doevendans,et al. Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium , 2016, Advanced healthcare materials.
[18] David L Kaplan,et al. Electrical and mechanical stimulation of cardiac cells and tissue constructs. , 2016, Advanced drug delivery reviews.
[19] Richard T. Lee,et al. Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction , 2009, Circulation.
[20] A. Boccaccini,et al. Development and characterization of novel electrically conductive PANI-PGS composites for cardiac tissue engineering applications. , 2014, Acta biomaterialia.
[21] H. Matsubara,et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.
[22] M. R. Miller,et al. Recent developments in nitric oxide donor drugs , 2007, British journal of pharmacology.
[23] Shu‐hong Li,et al. A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function After Implantation into Myocardial Infarct , 2015, Circulation.
[24] M. Ohkura,et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.
[25] M. Pasquali,et al. Biocompatible Carbon Nanotube–Chitosan Scaffold Matching the Electrical Conductivity of the Heart , 2014, ACS nano.
[26] R. Hajjar. Potential of gene therapy as a treatment for heart failure. , 2013, The Journal of clinical investigation.
[27] M. Ward,et al. eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction. , 2013, Cardiovascular therapeutics.
[28] A. Khademhosseini,et al. Injectable Graphene Oxide/Hydrogel-Based Angiogenic Gene Delivery System for Vasculogenesis and Cardiac Repair , 2014, ACS nano.
[29] Akshay S. Desai,et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial , 2016, The Lancet.
[30] G. Baxter,et al. Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies , 2016, Basic Research in Cardiology.
[31] N. Annabi,et al. Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair. , 2016, Biotechnology advances.
[32] M. Gladwin,et al. Strategies to increase nitric oxide signalling in cardiovascular disease , 2015, Nature Reviews Drug Discovery.
[33] T. Kudo,et al. Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice , 2017, Circulation research.
[34] J. Butler,et al. Nitrite Therapy Improves Left Ventricular Function During Heart Failure via Restoration of Nitric Oxide–Mediated Cytoprotective Signaling , 2014, Circulation research.
[35] B. Casadei,et al. Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. , 2014, Journal of molecular and cellular cardiology.
[36] Conor J. Walsh,et al. Drug and cell delivery for cardiac regeneration. , 2015, Advanced drug delivery reviews.
[37] J. Pilla,et al. MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction. , 2015, Biomaterials.
[38] S H Snyder,et al. Biological roles of nitric oxide. , 1992, Scientific American.
[39] M. Yacoub,et al. CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving , 2013, Global cardiology science & practice.
[40] Qinmei Wang,et al. Synthesis of water soluble, biodegradable, and electroactive polysaccharide crosslinker with aldehyde and carboxylic groups for biomedical applications. , 2011, Macromolecular bioscience.
[41] B. Strauer,et al. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.
[42] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[43] Joseph H. Gorman,et al. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition , 2014, Nature materials.
[44] Mohammad Ariful Islam,et al. Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction , 2015, Advanced science.
[45] G. Godeau,et al. Picrosirius Red Staining , 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[46] C. Heeschen,et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy , 2006, Proceedings of the National Academy of Sciences.
[47] C. Highley,et al. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. , 2007, Biomaterials.
[48] B. Wang,et al. Sustained viral gene delivery from a micro-fibrous, elastomeric cardiac patch to the ischemic rat heart. , 2017, Biomaterials.
[49] Sunil V. Rao,et al. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVA , 2015, American heart journal.
[50] A. Albertsson,et al. Degradable and Electroactive Hydrogels with Tunable Electrical Conductivity and Swelling Behavior , 2011 .
[51] Boguang Yang,et al. Development of Electrically Conductive Double‐Network Hydrogels via One‐Step Facile Strategy for Cardiac Tissue Engineering , 2016, Advanced healthcare materials.
[52] Fei Zhao,et al. Multifunctional Nanostructured Conductive Polymer Gels: Synthesis, Properties, and Applications. , 2017, Accounts of chemical research.
[53] W. Wagner,et al. Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences. , 2017, Biomaterials.
[54] E. Braunwald. The war against heart failure: the Lancet lecture , 2015, The Lancet.
[55] D. Schaffer,et al. Engineering biomaterial systems to enhance viral vector gene delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[56] Qiang Zhao,et al. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer. , 2017, Biomaterials.
[57] R. Lange,et al. Cardiac regeneration: current therapies-future concepts. , 2013, Journal of thoracic disease.
[58] D. Mancini,et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. , 2009, Journal of cardiac failure.
[59] M. Kutryk,et al. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. , 2015, Circulation research.
[60] A. Kochegarov,et al. New Trends in Heart Regeneration: A Review , 2016, Journal of stem cells & regenerative medicine.
[61] Baolin Guo,et al. Self-Healing Conductive Injectable Hydrogels with Antibacterial Activity as Cell Delivery Carrier for Cardiac Cell Therapy. , 2016, ACS applied materials & interfaces.
[62] Norman E. Miller. Glybera and the future of gene therapy in the European Union , 2012, Nature Reviews Drug Discovery.
[63] Boguang Yang,et al. A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair. , 2014, Biomaterials.
[64] R. Rafikov,et al. Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction , 2016, Journal of the American Heart Association.
[65] Xiaoping Song,et al. Mussel‐Inspired Conductive Cryogel as Cardiac Tissue Patch to Repair Myocardial Infarction by Migration of Conductive Nanoparticles , 2016 .
[66] J. Gorman,et al. Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction , 2014, Science Translational Medicine.
[67] J. Kalifa,et al. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction. , 2017, Acta biomaterialia.
[68] Sunil V. Rao,et al. Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. , 2016, Journal of the American College of Cardiology.
[69] S. Gerecht,et al. To Serve and Protect: Hydrogels to Improve Stem Cell-Based Therapies. , 2016, Cell stem cell.
[70] Jason A Burdick,et al. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. , 2015, The Journal of thoracic and cardiovascular surgery.
[71] J. Balligand,et al. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[72] Wei Wang,et al. A π-π conjugation-containing soft and conductive injectable polymer hydrogel highly efficiently rebuilds cardiac function after myocardial infarction. , 2017, Biomaterials.
[73] T. Rassaf,et al. Nitric Oxide Synthase Expression and Functional Response to Nitric Oxide Are Both Important Modulators of Circulating Angiogenic Cell Response to Angiogenic Stimuli , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[74] G. Felker,et al. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b). , 2014, JACC. Heart failure.
[75] Mehdi Nikkhah,et al. Nanoreinforced Hydrogels for Tissue Engineering: Biomaterials that are Compatible with Load‐Bearing and Electroactive Tissues , 2017, Advanced materials.
[76] Y. Yoon,et al. Cell Therapy with Embryonic Stem Cell-Derived Cardiomyocytes Encapsulated in Injectable Nanomatrix Gel Enhances Cell Engraftment and Promotes Cardiac Repair , 2014, ACS nano.
[77] J. Molkentin,et al. An emerging consensus on cardiac regeneration , 2014, Nature Medicine.
[78] F. Prósper,et al. Heart regeneration after myocardial infarction using synthetic biomaterials. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[79] Tal Dvir,et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome , 2009, Proceedings of the National Academy of Sciences.
[80] Y. S. Zhang,et al. Reduced Graphene Oxide-GelMA Hybrid Hydrogels as Scaffolds for Cardiac Tissue Engineering. , 2016, Small.
[81] Qiang Zhao,et al. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. , 2015, Biomaterials.
[82] Raymond M. Wang,et al. Decellularized myocardial matrix hydrogels: In basic research and preclinical studies. , 2016, Advanced drug delivery reviews.
[83] J. Hare,et al. Next-Generation Stem Cell Therapy: Genetically Modified Mesenchymal Stem Cells for Cardiac Repair , 2017, Cardiovascular Drugs and Therapy.
[84] Shoei-Shen Wang,et al. Injection of autologous bone marrow cells in hyaluronan hydrogel improves cardiac performance after infarction in pigs. , 2014, American journal of physiology. Heart and circulatory physiology.
[85] Zhijian Yang,et al. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction , 2017, Cardiovascular Drugs and Therapy.